Androgen receptor and soy isoflavones in prostate cancer (Review)

  • Authors:
    • Monika Kmetová Sivoňová
    • Peter Kaplán
    • Zuzana Tatarková
    • Lucia Lichardusová
    • Róbert Dušenka
    • Jana Jurečeková
  • View Affiliations

  • Published online on: December 11, 2018     https://doi.org/10.3892/mco.2018.1792
  • Pages: 191-204
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Androgens and androgen receptor (AR) play a critical role not only in normal prostate development, but also in prostate cancer. For that reason, androgen deprivation therapy (ADT) is the primary treatment for prostate cancer. However, the majority of patients develop castration‑resistant prostate cancer, which eventually leads to mortality. Novel therapeutic approaches, including dietary changes, have been explored. Soy isoflavones have become a focus of interest because of their positive health benefits on numerous diseases, particularly hormone‑related cancers, including prostate and breast cancers. An important strategy for the prevention and/or treatment of prostate cancer might thus be the action of soy isoflavones on the AR signaling pathway. The current review article provides a detailed overview of the anticancer potential of soy isoflavones (genistein, daidzein and glycitein), as mediated by their effect on AR.
View Figures
View References

Related Articles

Journal Cover

February 2019
Volume 10 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Sivoňová, M.K., Kaplán, P., Tatarková, Z., Lichardusová, L., Dušenka, R., & Jurečeková, J. (2019). Androgen receptor and soy isoflavones in prostate cancer (Review). Molecular and Clinical Oncology, 10, 191-204. https://doi.org/10.3892/mco.2018.1792
MLA
Sivoňová, M. K., Kaplán, P., Tatarková, Z., Lichardusová, L., Dušenka, R., Jurečeková, J."Androgen receptor and soy isoflavones in prostate cancer (Review)". Molecular and Clinical Oncology 10.2 (2019): 191-204.
Chicago
Sivoňová, M. K., Kaplán, P., Tatarková, Z., Lichardusová, L., Dušenka, R., Jurečeková, J."Androgen receptor and soy isoflavones in prostate cancer (Review)". Molecular and Clinical Oncology 10, no. 2 (2019): 191-204. https://doi.org/10.3892/mco.2018.1792